BACKGROUND: Glucagon-like peptide-2 (GLP-2) is a nutrient-dependent proglucagon-derived hormone that stimulates intestinal adaptive growth. Our aim was to determine whether exogenous GLP-2 increases resection-induced adaptation without diminishing endogenous proglucagon and GLP-2 receptor expression. METHODS: Rats underwent transection or 70% jejunoileal resection +/- GLP-2 infusion (100 microg/kg body weight/d) and were fed a semipurified diet with continuous infusion of GLP-2 or saline by means of jugular catheter. After 7 days, body weight, mucosal cellularity (dry mass, protein and DNA), crypt-villus height, and crypt cell proliferation (by bromodeoxyuridine staining) were determined. Plasma bioactive GLP-2 (by radioimmunoassay), proglucagon and GLP-2 receptor mRNA expression (by Northern blot and real-time reverse transcriptase quantitative polymerase chain reaction) were measured. GLP-2 receptor was colocalized to neuroendocrine markers by immunohistochemistry. RESULTS: Low-dose exogenous GLP-2 increased mucosal cellularity and crypt-villus height in the duodenum, jejunum, and ileum; enterocyte proliferation in the jejunal crypt; and duodenal and jejunal sucrase segmental activity. Plasma bioactive GLP-2 concentration increased 70% upon resection, with an additional 54% increase upon GLP-2 infusion in resected rats (P < .05). Ileal proglucagon mRNA expression increased with resection, and exogenous ileum GLP-2 failed to blunt this response. Exogenous GLP-2 increased ileum GLP-2 receptor expression 3-fold in resected animals and was colocalized to vasoactive intestinal peptide-positive and endothelial nitric oxide synthase-expressing enteric neurons and serotonin-containing enteroendocrine cells in the jejunum and ileum of resected rats. CONCLUSIONS: Exogenous GLP-2 augments adaptive growth and digestive capacity of the residual small intestine in a rat model of mid-small bowel resection by increasing plasma GLP-2 concentrations and GLP-2 receptor expression without diminishing endogenous proglucagon expression.
BACKGROUND:Glucagon-like peptide-2 (GLP-2) is a nutrient-dependent proglucagon-derived hormone that stimulates intestinal adaptive growth. Our aim was to determine whether exogenous GLP-2 increases resection-induced adaptation without diminishing endogenous proglucagon and GLP-2 receptor expression. METHODS:Rats underwent transection or 70% jejunoileal resection +/- GLP-2 infusion (100 microg/kg body weight/d) and were fed a semipurified diet with continuous infusion of GLP-2 or saline by means of jugular catheter. After 7 days, body weight, mucosal cellularity (dry mass, protein and DNA), crypt-villus height, and crypt cell proliferation (by bromodeoxyuridine staining) were determined. Plasma bioactive GLP-2 (by radioimmunoassay), proglucagon and GLP-2 receptor mRNA expression (by Northern blot and real-time reverse transcriptase quantitative polymerase chain reaction) were measured. GLP-2 receptor was colocalized to neuroendocrine markers by immunohistochemistry. RESULTS: Low-dose exogenous GLP-2 increased mucosal cellularity and crypt-villus height in the duodenum, jejunum, and ileum; enterocyte proliferation in the jejunal crypt; and duodenal and jejunal sucrase segmental activity. Plasma bioactive GLP-2 concentration increased 70% upon resection, with an additional 54% increase upon GLP-2 infusion in resected rats (P < .05). Ileal proglucagon mRNA expression increased with resection, and exogenous ileum GLP-2 failed to blunt this response. Exogenous GLP-2 increased ileum GLP-2 receptor expression 3-fold in resected animals and was colocalized to vasoactive intestinal peptide-positive and endothelial nitric oxide synthase-expressing enteric neurons and serotonin-containing enteroendocrine cells in the jejunum and ileum of resected rats. CONCLUSIONS: Exogenous GLP-2 augments adaptive growth and digestive capacity of the residual small intestine in a rat model of mid-small bowel resection by increasing plasma GLP-2 concentrations and GLP-2 receptor expression without diminishing endogenous proglucagon expression.
Authors: P B Jeppesen; B Hartmann; J Thulesen; J Graff; J Lohmann; B S Hansen; F Tofteng; S S Poulsen; J L Madsen; J J Holst; P B Mortensen Journal: Gastroenterology Date: 2001-03 Impact factor: 22.682
Authors: M B Gillingham; E M Dahly; H V Carey; M D Clark; K R Kritsch; D M Ney Journal: Am J Physiol Gastrointest Liver Physiol Date: 2000-05 Impact factor: 4.052
Authors: P A Kitchen; A J Fitzgerald; R A Goodlad; N F Barley; M A Ghatei; S Legon; S R Bloom; A Price; J R Walters; A Forbes Journal: Am J Physiol Gastrointest Liver Physiol Date: 2000-03 Impact factor: 4.052
Authors: K Ljungmann; B Hartmann; P Kissmeyer-Nielsen; A Flyvbjerg; J J Holst; S Laurberg Journal: Am J Physiol Gastrointest Liver Physiol Date: 2001-09 Impact factor: 4.052
Authors: Adam S Brinkman; Sangita G Murali; Stacy Hitt; Patrick M Solverson; Jens J Holst; Denise M Ney Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-06-28 Impact factor: 4.052
Authors: Jason L S Leen; Angelo Izzo; Chandani Upadhyay; Katherine J Rowland; Philip E Dubé; Steven Gu; Scott P Heximer; Christopher J Rhodes; Daniel R Storm; P Kay Lund; Patricia L Brubaker Journal: Endocrinology Date: 2010-12-15 Impact factor: 4.736
Authors: Aaron P Garrison; Christopher M Dekaney; Douglas C von Allmen; P Kay Lund; Susan J Henning; Michael A Helmrath Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-12-31 Impact factor: 4.052